Correction to: “Validation and Limitations of the PANOMEN-3 Predictive Model for Tumor Recurrence and Progression in Pituitary Tumors” - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction to: “Validation and Limitations of the PANOMEN-3 Predictive Model for Tumor Recurrence and Progression in Pituitary Tumors”

  • January 22, 2026

Share

Objective:

To correct the author list in the previously published article.

Key Findings:
  • Correction of author name from 'Julia García' to 'Julia García-Arabehety'.
Interpretation:

The correction ensures proper attribution of authorship in the published research.

Limitations:
Conclusion:

The article has been corrected online to reflect the accurate author name.

Original Source(s)

Correction to: “Validation and Limitations of the PANOMEN-3 Predictive Model for Tumor Recurrence and Progression in Pituitary Tumors”

  • January 22, 2026

Related Content

From clinician to coach: promoting early relational health and language development in primary pediatric care

Medical Oddities: Could GLP-1s Curb Violence?

Five studies, one question: are we overlooking hidden drivers of health?

Can SGLT2 Inhibitors Affect Dementia?

A target trial emulation using Veterans Affairs electronic health records examined neuropsychiatric outcomes associated with SGLT2 inhibitor use.